NDC 51672-2075-01 - Bacitracin Zinc
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-2075
- Requested NDC
- 51672-2075-01
- Package NDCs from labels
- 51672-2075-1, 51672-2075-2, 51672-2075-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-08-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Bacitracin Zinc - A-S Medication Solutions | A-S Medication Solutions | 2026-08-07 | HUMAN OTC DRUG LABEL |
| Bacitracin Zinc Ointment USP | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2026-04-10 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-2075-1 | Bacitracin Zinc | 15 g in 1 TUBE | OINTMENT | 15 | 6 | |
| 51672-2075-1 | Bacitracin Zinc | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-2075-2 | Bacitracin Zinc | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-2075-2 | Bacitracin Zinc | 30 g in 1 TUBE | OINTMENT | 30 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-2075 | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 4 | Current NDC, Legacy NDC, 4 package rows | 20241105_4afdeedf-9cdf-47d6-919f-ea907fda0290.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-2075-1 | GM - Gram | 51672-2075 | e945b097-4fbc-49ee-be04-cda62ddd0a1b | 1 | 2013-02-13 |
| 51672-2075-2 | GM - Gram | 51672-2075 | 9d1461f6-ec4f-41a4-abbd-699c44ef8cb8 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Bacitracin Zinc | ACTIVE INGREDIENT | 89Y4M234ES | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Bacitracin | ACTIVE MOIETY | 58H6RWO52I | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| mineral oil | INACTIVE INGREDIENT | T5L8T28FGP | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ChapStick Classic Original | WHITE PETROLATUM | Haleon US Holdings LLC | 42fe0f4a-efb7-4e70-a359-db7dc2ac9905 | 2024-03-19 | Warnings | 4T6H12BN9U |
| ChapStick Classic Spearmint | WHITE PETROLATUM | Haleon US Holdings LLC | 74354d8e-c265-4a27-9715-1a4c157ad890 | 2024-03-19 | Warnings | 4T6H12BN9U |
| Antibiotic | BACITRACIN ZINC, POLYMYXIN B SULFATE | CVS PHARMACY, INC | 32e92acf-2e48-4933-8e08-e1df650e7d19 | 2024-03-15 | Warnings | M004 89Y4M234ES |
| Cetaphil Healing | PETROLATUM | Galderma Laboratories, L.P. | e996db17-bd4d-4b06-bb9a-983dbdec8022 | 2024-03-13 | Warnings | 4T6H12BN9U |
| Major Bacitracin | BACITRACIN | Major Pharmaceuticals | 13288efb-e282-68f8-e063-6294a90ae712 | 2024-03-08 | Warnings | M004 |
| mama bear DIAPER RASH Skin Protectant | LANOLIN AND PETROLATUM | AMAZON.COM SERVICES LLC | cda9ca47-b668-4a65-908d-80b9a6515bd7 | 2024-03-06 | Warnings | 4T6H12BN9U |
| UniShield TRIPLE ANTIBIOTIC | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Unishield | 00b85d3a-322b-43c1-b022-5f6ed50c6609 | 2024-03-02 | Warnings | M004 89Y4M234ES |
| PREPARATION H | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Haleon US Holdings LLC | 507c08ab-a98b-33fe-e2ac-eb9b9a810d5a | 2024-02-29 | Warnings | 4T6H12BN9U T5L8T28FGP |
| Preparation H Rapid Relief | GLYCERIN, LIDOCAINE, PETROLATUM, AND PHENYLEPHRINE HYDROCHLORIDE | Haleon US Holdings LLC | 699310e8-1a93-40b4-a8f4-a765be4a0cb1 | 2024-02-29 | Warnings | 4T6H12BN9U |
| XtraCare Creamy Petroleum Jelly Cocoa Butter Enriched | PETROLEUM | Rejoice International | 580d76ee-ea89-426e-bd25-7a58481e9795 | 2024-02-28 | Warnings | 4T6H12BN9U |
| XtraCare Creamy Petroleum Jelly Vitamin E enriched | PETROLATUM | Rejoice International | 2c382a50-93d2-4d28-b7a4-1702b20b7139 | 2024-02-28 | Warnings | 4T6H12BN9U |
| Triple Antibiotic Plus Pain Relief | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Chain Drug Marketing Association Inc. | 1277942d-753f-ab69-e063-6394a90a496a | 2024-02-28 | Warnings | M004 89Y4M234ES |
| Triple Antibiotic with Pain Relief | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HYDROCHLORIDE | Safetec of America, Inc. | ca1df4a0-844d-4b1d-b972-f2704a8ebbab | 2024-02-16 | Warnings | M004 89Y4M234ES |
| Single Antibiotic | BACITRACIN ZINC | Safetec of America, Inc. | 9993c204-6e61-4da3-90ef-2b7dfa09c920 | 2024-02-14 | Warnings | M004 1366116 89Y4M234ES |
| Rugby Petrolatum Hydrating Skin Protectant | PETROLATUM | Rugby Laboratories | ad63e345-1fe8-4f9a-a32e-8dfcde31bedc | 2024-02-12 | Warnings | 4T6H12BN9U |
| A and D | PETROLATUM | Safetec of America, Inc. | b9afda3a-9e1d-46c1-b7aa-c3143caf709e | 2024-02-09 | Warnings | 4T6H12BN9U |
| Single Antibiotic with Neomycin | NEOMYCIN SULFATE | Safetec of America | e989cf7e-f3d1-42d2-af45-fc80095b97cb | 2024-02-08 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Safetec of America, Inc. | 96c41fc1-81f9-4757-abc6-867b5383ed5d | 2024-02-07 | Warnings | M004 89Y4M234ES |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Safetec of America, Inc. | 2c2aa8af-2adb-4f59-ac20-15818d0e28e7 | 2024-02-07 | Warnings | M004 89Y4M234ES |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Safetec of America, Inc. | 03c05028-5a5f-4690-a836-cc1b1044ab39 | 2024-02-05 | Warnings | M004 89Y4M234ES |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.